Abstract
Lung and heart–lung transplantation are established therapies for children with end-stage lung or congenital heart disease (CHD)/pulmonary vascular disease (PVD) in which there are no other therapeutic options. The most common indications for transplantation differ by age group. Cystic fibrosis is the most common overall indication of the lung recipients for the 12–17-year age group. In children younger than 1 year, the most common indications are CHD/PVD and diffuse lung disease from surfactant abnormalities. Additional diagnoses include transplant and nontransplant bronchiolitis obliterans and pulmonary fibrosis/interstitial pneumonitis. This chapter reviews pretransplant, donor, and posttransplant imaging evaluation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldfarb SB, Levvey BJ, Cherikh WS, Chambers DC, Khush K, Kucheryavaya AY, et al. Registry of the International Society for Heart and Lung Transplantation: eleventh official pediatric lung and heart/lung transplantation report–2017. J Heart Lung Transplant. 2017;36(10):1070–9.
Zander DS, Baz MA, Visner GA, Staples ED, Donnelly WH, Faro A, et al. Analysis of early deaths after isolated lung transplantation. Chest. 2001;120:225–32.
Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–9.
Prekker ME, Nath DS, Walker AR, Johnson AC, Hertz MI, Herrington CS, et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2006;25:371–8.
Medina LS, Siegel MJ. CT of complications in pediatric lung transplantation. Radiographics. 1994;14:1341–9.
Choong CK, Sweet SC, Zoole JB, Guthrie TJ, Mendeloff EN, Haddad FJ, et al. Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome. J Thorac Cardiovasc Surg. 2006;131:198–203.
Liu M, Wortey S, Arrigain S, Aurora P, Ballmann M, et al. Respiratory viral infections within one year after pediatric lung transplant. Transpl Infect Dis. 2009;11(4):304–12.
Siegel MJ, Lee EY, Sweet SC, Hildebolt C. CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft. AJR Am J Roentgenol. 2003;181:1125–31.
Boyle GJ, Michaels MG, Webber SA, Knisely AS, Kurland G, Cipriani LA, et al. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr. 1997;131:309–13.
Lau DM, Siegel MJ, Hildebolt CF, Cohen AH. Bronchiolitis obliterans syndrome: thin-section CT diagnosis of obstructive changes in infants and young children after lung transplantation. Radiology. 1998;208:783–8.
Siegel MJ, Bhalla S, Gutierrez FR, Hildebolt C, Sweet S. Post-lung transplantation bronchiolitis obliterans syndrome: usefulness of expiratory thin-section CT for diagnosis. Radiology. 2001;220:455–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Visner, G., Lee, E.Y. (2020). Pediatric Lung Transplantation. In: Cleveland, R., Lee, E. (eds) Imaging in Pediatric Pulmonology. Springer, Cham. https://doi.org/10.1007/978-3-030-23979-4_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-23979-4_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23978-7
Online ISBN: 978-3-030-23979-4
eBook Packages: MedicineMedicine (R0)